 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Results for Development |
| Street 1: | 1100 15th St. |
| Street 2: | |
| City: | Washington DC |
| Province: | |
| Post Code: | |
| Country: | United States of America |
| Phone: | 202.470.5738 |
| Organization Email: | chmi@r4d.org |
| Web Site: | http://www.Healthmarketinnovations.org |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Developed Country NGO |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Non-Governmental Organization |
| Organization Type - Secondary: | None |
| Organization Description: | |
| Results for Development Institute (R4D) is a non-profit organization whose mission is to unlock solutions to tough development challenges that prevent people in low- and middle-income countries from realizing their full potential. Using multiple approaches in multiple sectors, including Global Education, Global Health, Governance and Market Dynamics, R4D supports the discovery and implementation of new ideas for reducing poverty and improving lives around the world. The Center for Health Market Innovations profiles TB programs utilizing innovative approaches to improve case detection, reduce diagnostic delays, and lower the cost of care. This page provides information about the program's countries of operation, their primary sources of funding, and their delivery and financing approaches used to improve access, quality, and affordability for TB-affected patients. |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Advocacy Funding, including innovative and optimized approach to funding TB Care Research and Development |
Other Organization Information | |
| Total number of staff in your organization: | 51 - 99 |
| Number of full-time staff who are directly involved with TB: | 1 - 5 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Attendance at a TB related event |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Network with other partners |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | No |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| N/A | |
Geographical Reach | |
| Which country is your headquarters located in: | United States of America |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Afghanistan Argentina Bangladesh Bolivia Cambodia Cameroon Ethiopia Haiti India Indonesia Kenya Lao People's Democratic Republic Malawi Nepal Nicaragua Nigeria Pakistan Peru Philippines Rwanda Senegal South Africa Sri Lanka Sudan Thailand Uganda United Republic of Tanzania Viet Nam Zambia Zimbabwe |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
Research: The Center for Health Market Innovations (CHMI; healthmarketinnovations.org) profiles close to 70 programs that engage in emerging practices of tuberculosis (TB) healthcare in low- and middle-income countries. These programs use innovative delivery mechanisms and information communications technologies to improve access to TB diagnostic and treatment services, patient and provider adherence to care protocols, and affordability of healthcare for the poor. These approaches include integrating informal providers into TB treatment programs and social franchises and using mobile phones for data collection and treatment surveillance. We analyze data from the CHMI database and external evidence to provide an overview of emerging practices for improving TB healthcare with the goal of highlighting promising approaches and identifying knowledge gaps in the evidence base for future research. • More than 45% of CHMI’s TB programs are concentrated in East and West Africa and 97% are private, not-for-profit models. • Emerging practices profiled by CHMI tend to focus on three major issues in TB care: correctly identifying individuals with TB, recruiting patients into TB treatment, and ensuring treatment compliance. • Some programs are training IPs to offer TB services and improve access to diagnostics and treatment. Other programs are using mobile technologies to support TB surveillance and patient adherence to drug regiments. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | May 28, 2014 |
| Last updated: | June 11, 2014 |